Global Digital Biomarkers Market: Regional Insights
Based on geography, the global digital biomarkers market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
Among regions, North America is expected to gain highest share in the market during the forecast period owing to the rise in incidence of chronic diseases, increasing adoption of digital healthcare solution or services, and outbreak of COVID-19 in the region. For instance, digital biomarkers can radically transform the standard of care for chronic conditions that are complex to manage. Chronic diseases, such as cardiovascular diseases, cancer, and diabetes, are the leading causes of death and disability in the U.S., according to the U.S. Centers for Disease Control & Prevention (CDC). This in turn is expected to augment the market growth.
Europe and Asia Pacific are also expected to witness robust growth in the global digital biomarkers market owing to the increasing smartphone penetration, increasing prevalence of chronic diseases, the outbreak of COVID-19, and increasing adoption of digital healthcare solution and services in these regions. For instance, according to the European Chronic Disease Alliance (ECDA), chronic diseases, such as cardiovascular disease, stroke, cancer, diabetes, and respiratory diseases, are the leading cause of mortality in Europe. Each year, cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the EU.
Digital Biomarkers Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients